CS logo
small CS logo
Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building

Detroit, Michigan, United States
Cancer treatment center in Detroit, Michigan
4100 John R St, Detroit, MI 48201
123 Beds

About Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building


The Barbara Ann Karmanos Cancer Institute, headquartered in Detroit, is the largest cancer research and provider network in Michigan and has 16 treatment locations. It is one of 51 National Cancer Institute-designated comprehensive cancer treatment and research centers in the United States.
There are 123 beds in Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building


During the past decade, Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building


According to Clinical.Site data, the most researched conditions in "Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building" are "Influenza, Human" (1 trials), "Malignant Melanoma" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building" in a lesser frequency.

Clinical Trials Intervention Types at Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building


Most popular intervention types in "Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Cobimetinib" (1 trials), "Docetaxel" (1 trials), "oseltamivir" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building


The vast majority of trials in "Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building" are 3 trials for "All" genders.

Clinical Trials Status at Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building


Currently, there are NaN active trials in "Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".